Von Willebrand Factor and Hemostasis: A Comprehensive Report

Verified

Added on  2025/05/04

|9
|1650
|246
AI Summary
Desklib provides solved assignments and past papers to help students succeed.
Document Page
Running head: Heart and Cardiovascular System 1
HEART AND CARDIOVASCULAR SYSTEM
tabler-icon-diamond-filled.svg

Paraphrase This Document

Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser
Document Page
Running head: Heart and Cardiovascular System 2
Table of Contents
Introduction......................................................................................................................................3
What has been meant by von Willebrand Factor?...........................................................................3
Where would this have been expected to identify it within body?..................................................4
Information regarding subcellular localization along with its stimulations as well as its release?. 4
What role vWF does play within hemostasis?.................................................................................4
Description regarding clotting cascade............................................................................................5
What happens in case there has been fall within quantity as well as operations of vWF?..............5
Conclusion.......................................................................................................................................5
References........................................................................................................................................5
Document Page
Running head: Heart and Cardiovascular System 3
Introduction
This study depends on the heart and cardiovascular framework. In addition to that, this appraisal
centers on a protein, which assumes a basic job in haemostasis and von, Willebrand Factor
(vWF).
What has been meant by von Willebrand Factor?
VWF is a protein that is one of a few parts of the coagulation framework that work in order and
in grouping to quit seeping inside the body. As opined by Sahebkar et al. (2016), VWF testing
estimates the measure of the protein present in blood and decides how well the protein capacities.
Ordinarily, when a vein is harmed and draining starts, VWF shapes a glue connect between
initiated cell pieces called platelets and the damage site. This is trailed by the bunching (total) of
platelets at the site and a progression of activities alluded to an actuation of the coagulation
course, bringing about the development of a steady blood cluster.
According to Randi & Laffan (2017), VWF further influences thickening by affecting the
accessibility of coagulation factor VIII. VWF conveys considering VIII factor, builds its half-
life, and discharges it as fundamental. On the off chance that the measure of the practical VWF is
lacking, at that point platelet adherence are influenced, dimensions of factor VIII could be
diminished, blood clump arrangement takes longer and in this way draining drawn out. This
inadequacy causes a condition eluded to as von Willebrand Disease (VWD).
As said by Albánez et al. (2016), VWD is the most widely recognized acquired draining issue. It
is a gathering of conditions related to delayed seeping because of inadequate as well as deficient
VWF. VWD is isolated into various kinds and sub-types, including:
Document Page
Running head: Heart and Cardiovascular System 4
Type 1 - With this kind of VWD, there is a lessening in the measure of VWF created, yet the
VWF capacities remain typical. Dimensions of factor VIII are likewise commonly low yet might
be typical. As stated by Bodó et al. (2015), this is the most widely recognized kind of VWD,
representing about 75% of cases. It will in general reason wounding and mellow to direct dying.
For example, industrious nosebleeds, overwhelming menstrual periods and delayed draining after
labor, injury, dental methods, and medical procedures. Manifestations and the seriousness of
draining will change from individual to individual and from scene to scene.
Type 2 - This category is related to a typical measure of VWF, yet the VWF does not work
regularly. Draining might be progressively serious with this category. This type is additionally
partitioned into types such as 2A, 2B, 2M, 2N.
Type 3 – This uncommon category is related with almost no VWF creation, low factor VIII
dimensions, and moderate to extreme side effects as usually identified in early stages in view of
early draining scenes.
Occasionally, VWD might be expected to a procured VWF lack, where there is no family or
individual draining history up to the moment that signs and manifestations create.
As opined by Noone et al. (2016), Von Willebrand factor testing incorporates VWF antigen,
which estimates the measure of VWF, and VWF action (otherwise called Ristocetin Cofactor),
which assesses the capacity of VWF. A few research facilities may offer a board that
incorporates both of these tests alongside a factor VIII movement test.
Where would this have been expected to identify it within body?
A remedial prosperity history is fundamental to help choose whether various relatives have been
resolved to have a depleting issue or have experienced reactions. Tests that survey coagulation
time and a patient's ability to shape coagulation may be mentioned. A coagulation factor test
tabler-icon-diamond-filled.svg

Paraphrase This Document

Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser
Document Page
Running head: Heart and Cardiovascular System 5
called a test, and tests estimating platelet work additionally might be performed. According to
Lenting et al. (2015), the VWF antigen test estimates the measure of VWF in blood plasma.
Patients with VWD ordinarily have <50% of ordinary VWF in their plasma. After VWD is
affirmed, a test to decide the accurate kind is performed.
Information regarding sub cellular localization along with its stimulations as well as its
release
Factor VIII-related antigen was restricted ultra fundamentally in a combination of human tissues
(smooth muscle, skeletal muscle, chest, thin hemangioma) with the usage of a low temperature
embeddings protein in A-gold technique with both polyclonal and monoclonal antiserum
composed against von Willebrand factor. As indicated by Randi and Laffan (2017), each
endothelial cell examined restricted the counter von Willebrand factor to Weibel-palade bodies.
Reservoir of the endoplasmic reticulum and cytoplasm vacuoles were similarly stamped. These
results set up the scattering of factor VIII-related antigen at the sub cell level. The watched
apportionment recommends that the endothelial cells fuse von Willebrand factor, store it in
Weibel-Palade bodies, and release it by exocytose. These discernments give in vivo confirmation
to past biochemical and immunocytochemical data got from focuses on refined endothelial cells.
What role vWF does play within hemostasis?
VWF has a focal job in essential haemostasis where it intervenes platelet bond to harmed
vascular sub endothelium and in this manner platelet conglomeration. Following vascular
damage, VWF ties explicitly to febrile collagen type III and I. As stated by Bodó et al. (2015),
restricting locales for febrile collagen have been recognized inside VWF areas A1 And A3,
Document Page
Running head: Heart and Cardiovascular System 6
despite the fact that mutagenesis considers recommending that the significant site in VWF space
A3 and the minor site in area A1 connect with various focuses on collagen. It was accounted for
that the A3 area is vital and adequate to help authoritative to febrile collagen type I and III, while
A1 space is associated with official to collagen type VI.
Description regarding clotting cascade
As said by Albánez et al. (2016), harm to vein dividers uncovered tissue factor-containing cells
from basic cell layers to the circulation system. The set off an extracellular course including
successive serine protease initiations: TF/FVII is actuated via auto-cleavage to TF/FVIIa, which
alongside FVIIIa (cofactor) changes over FIX to FIXa, which changes over FX to FXa (despite
the fact that TF/FVIIa can likewise straightforwardly convert FX to FXa), which alongside FVa
(cofactor) changes over FII (prothrombin) to FIIa (thrombin), which changes over fibrinogen to
fibrin, prompting fibrin testimony and the enactment of platelets to shape blood clusters (the
actuation of FXIII to FXIIIa balances out the fibrin coagulation by cross-connecting it).
What happens in case there has been fall within quantity as well as operations of vWF?
At the point when a vein is harmed and begins dying, platelets together with some coagulating
Components structure a fitting at the area of damage. Therefore, the vein stops bleeding. As
opined by Noone et al. (2016), the plasma protein which permits or encourages the platelets to
stay with one another and structure a bunch is the von Willebrand factor (VWF). It additionally
conveys factor VIII. At that point when there is abatement in plasma levels or imperfection in the
VWF, the capacity of the blood to cluster diminishes prompting an overwhelming and nonstop
seeping after damage which is named as von Willebrand issue or ailment (VWD). This may
cause inward organ harm and once in a while may prompt passing.
Document Page
Running head: Heart and Cardiovascular System 7
Conclusion
This study focuses on von Willebrand factor. VWF is a protein that is one of a few parts of the
coagulation framework that work in order and in grouping to quit seeping inside the body.
Detailed information according to subcellular localization was discussed here. It can be
concluded that roles of vWF were discussed which play a vital role in haemostasis. A brief
description about coagulation cascade and the situation if vWF function lacks was discussed
here.
tabler-icon-diamond-filled.svg

Paraphrase This Document

Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser
Document Page
Running head: Heart and Cardiovascular System 8
References
Albánez, S., Ogiwara, K., Michels, A., Hopman, W., Grabell, J., James, P., & Lillicrap, D.
(2016). Aging and ABO blood type influence von Willebrand factor and factor VIII
levels through interrelated mechanisms. Journal of Thrombosis and Haemostasis, 14(5),
953-963. Retrieved on 21 May 2019. Retrieved from:
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.13294
Bodó, I., Eikenboom, J., Montgomery, R., Patzke, J., Schneppenheim, R., Di Paola, J., &
Subcommittee on von Willebrand Factor. (2015). Plateletdependent von Willebrand
factor activity. Nomenclature and methodology: communication from the SSC of the
ISTH. Journal of Thrombosis and Haemostasis, 13(7), 1345-1350. Retrieved on 21 May
2019. Retrieved from: https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.12964
Lenting, P. J., Christophe, O. D., & Denis, C. V. (2015). von Willebrand factor biosynthesis,
secretion, and clearance: connecting the far ends. Blood, 125(13), 2019-2028. Retrieved
on 21 May 2019. Retrieved from:
http://www.bloodjournal.org/content/bloodjournal/125/13/2019.full.pdf?sso-
checked=true
Noone, D. G., Riedl, M., Pluthero, F. G., Bowman, M. L., Liszewski, M. K., Lu, L., ... & Budde,
U. (2016). Von Willebrand factor regulates complement on endothelial cells. Kidney
international, 90(1), 123-134. Retrieved on 21 May 2019. Retrieved from:
http://www.bloodjournal.org/content/bloodjournal/126/17/2038.full.pdf
Document Page
Running head: Heart and Cardiovascular System 9
Randi, A. M., & Laffan, M. A. (2017). Von Willebrand factor and angiogenesis: basic and
applied issues. Journal of Thrombosis and Haemostasis, 15(1), 13-20. Retrieved on 21
May 2019. Retrieved from: https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.13551
Sahebkar, A., Serban, C., Ursoniu, S., Mikhailidis, D. P., Undas, A., Lip, G. Y., ... & Rysz, J.
(2016). The impact of statin therapy on plasma levels of von Willebrand factor
antigen. Thrombosis and Haemostasis, 115(03), 520-532. Retrieved on 21 May 2019.
Retrieved from:
https://www.researchgate.net/profile/Maciej_Banach/publication/283329520_The_impact
_of_statin_therapy_on_plasma_levels_of_von_Willebrand_factor_antigen_A_systematic
_review_and_meta-analysis_of_randomized_placebo-controlled_trials/links/
5660244808ae1ef929857479.pdf
chevron_up_icon
1 out of 9
circle_padding
hide_on_mobile
zoom_out_icon
[object Object]